Use of Concept of Chemotherapy-Equivalent Biologically Effective Dose to Provide Quantitative Evaluation of Contribution of Chemotherapy to Local Tumor Control in Chemoradiotherapy Cervical Cancer Trials

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 5, 2008, Pages 1538-1543

  Plataniotis, George A ^a   Dale, Roger G ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Cervical cancer; Radiation equivalent; Radiochemotherapy

Indexed keywords

ALGEBRA; CHEMOTHERAPY; CONCURRENCY CONTROL; ONCOLOGY; RADIOTHERAPY; TRANSMISSION CONTROL PROTOCOL;

BIOLOGICALLY EFFECTIVE DOSES; CERVICAL CANCER; CERVICAL CANCERS; CHEMORADIOTHERAPY; CONCURRENT CHEMORADIOTHERAPY; LINEAR QUADRATICS; LOCAL CONTROLS; LOCAL TUMOR CONTROLS; POISSON MODELS; QUANTITATIVE EVALUATIONS; RADIOCHEMOTHERAPY; RANDOMIZED CONTROLLED TRIALS; TUMOR CONTROL PROBABILITIES; TUMOR VOLUMES;

TUMORS;

ANTIINFECTIVE AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIOSENSITIVITY; TUMOR VOLUME; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; CISPLATIN; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; PROBABILITY; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 56349113670     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.06.1911     Document Type: Article

References (33)

1. National Institutes of Health. Cervical cancer: NIH consensus statement. Vol. 14. No. 1 (1996), NIH Office of Medical Applications of Research, Bethesda p. 15-16
2. Lanciano R.M., Won M., Coia L.R., et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 Patterns of Care studies. Int J Radiat Oncol Biol Phys 20 (1991) 667-676
3. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
4. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
5. Peters W.A., Liu P.Y., Barrett R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high risk, early stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
6. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
7. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
8. Lorvidhaya V., Chitapanaraux I., Sangruchi S., et al. Concurrent mitomycin-C, 5-fluorouracil and radiotherapy in the treatment of locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 55 (2003) 1226-1232
9. Roberts K.B., Urdaneta N., Vera R., et al. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous cell carcinoma of the cervix. Int J Cancer Radiat Oncol Invest 90 (2000) 206-223
10. Green J., Kirwan J., Tierney J., et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Library 4 (2007) 1-42
11. Lukka H, Hirte H, Fyles A, et al., and Members of the Gynecology Cancer Disease Site Group. Primary treatment for locally advanced cervical cancer: Concurrent platinum-based chemotherapy and radiation. Practice Guideline Report No. 4-5. Program in Evidence Based Care. A Cancer Care Ontario Program. Available at: http://www.CancerCare.on.ca/pdf/pebc4-5s.pdf. Accessed January 15, 2008.
12. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet 358 (2001) 781-786
13. Thomas G.M. Improved treatment for cervical cancer-Concurrent chemotherapy and radiotherapy. N Engl J Med 340 (1999) 1198-1199
14. Pearcey R., Brundage M., Drouin P., et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 20 (2002) 966-972
15. Tseng C.J., Chang C.T., Lai C.H., et al. A randomised trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol 66 (1997) 52-58
16. Whitney C.W., Sauser W., Bundy B.N., et al. Randomised comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB/IVA in carcinoma of the cervix with negative lymph nodes: A Gynecologic Oncology and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
17. Thomas G.M., Dembo A., Ackerman I., et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. Gynecol Oncol 69 (1998) 137-145
18. Wong L.C., Choo Y.C., Choy D., et al. Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer. Gynecol Oncol 35 (1989) 159-163
19. Phillips R.A., and Tolmach L.J. Repair of potentially lethal damage in X-irradiated HeLa cells. Radiat Res 29 (1966) 413-432
20. Fu K.K. Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer 55 Suppl. (1985) 2123-2130
21. Burghardt E., Baker J., Tulusan A.H., et al. Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 70 (1992) 648-655
22. Mayr N.A., Yuh W.T., Eng J., et al. Tumor size evaluated by pelvic examination compared with 3D MRI quantitative analysis in the prediction of outcome for cervical cancer. Int J Radiat Oncol Biol Phys 39 (1997) 395-404
23. Lim K., Chan P., Dinniwell R., et al. Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: Radiobiologic modeling and correlation with tumor hypoxia. Int J Radiat Oncol Biol Phys 70 (2008) 126-133
24. Fyles A., Keane T.J., Barton M., et al. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 25 (1992) 273-279
25. Jones B., and Hopkins K.I. Chemotherapy and other adjuvant therapies. In: Dale R., and Jones B. (Eds). Radiobiological modelling in radiation oncology (2007), British Institute of Radiology, London 234-245
26. Dale R.G. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 58 (1985) 515-528
27. Dale R.G., Coles I.P., Deehan C., et al. Calculation of integrated biological response in brachytherapy. Int J Radiat Oncol Biol Phys 38 (1997) 633-642
28. Fowler J. Correction to Kasibhatla, et al. How much radiation is the chemotherapy worth in advanced head-and-neck cancer?. Int J Radiat Oncol Biol Phys 68 (2007) 1491-1495
29. Kagei K., Tokuuye K., Okumura T., et al. Long-term results of proton beam therapy for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 55 (2003) 1265-1271
30. Jones B., and Dale R.G. The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy. Br J Radiol 78 (2005) 939-944
31. Roberts S.A., and Hendry J.H. Inter-tumor heterogeneity and tumor control. In: Dale R., and Jones B. (Eds). Radiobiological modelling in radiation oncology (2007), British Institute of Radiology, London 168-195
32. Jones B., and Dale R.G. Radiobiological modeling and clinical trials. Int J Radiat Oncol Biol Phys 48 (2000) 259-265
33. Bentzen S.M. Towards evidence based radiation oncology: Improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother Oncol 46 (1998) 5-18